Neurocrine Biosciences | 现金及等价物

Cash And Equivalent 更改 日
AbbVie USD 18.07B 4.78B 2024-03
Acadia Pharmaceuticals USD 204.74M 16.09M 2024-03
Agios Pharmaceuticals USD 118.76M 30.56M 2024-03
ALKERMES USD 420.75M 392.62M 2024-03
Alnylam Pharmaceuticals USD 681.88M 130.81M 2024-03
Amgen USD 9.71B 1.24B 2024-03
Biogen USD 1.07B 24.5M 2024-03
BioMarin Pharmaceutical USD 747M 8.13M 2024-03
Cytokinetics USD 119.98M 6.95M 2024-03
Dynavax Technologies USD 132.03M 18.25M 2024-03
Exelixis USD 259.56M 137.3M 2024-03
Gilead Sciences USD 4.72B 3.71B 2024-03
Halozyme Therapeutics USD 164.63M 46.26M 2024-03
Incyte USD 3.35B 132.83M 2024-03
Intra Cellular Therapies USD 139.82M 7.95M 2024-03
Ionis Pharmaceuticals USD 348.89M 50.38M 2024-03
Neurocrine Biosciences USD 396.3M 102.6M 2024-03
Pfizer USD 719M 2.43B 2024-03
Prothena USD 546.51M 72.32M 2024-03
Regeneron Pharmaceuticals USD 2.6B 13.64B 2024-03
Repligen USD 780.62M 29.29M 2024-03
Sarepta Therapeutics USD 427.29M 114.64M 2024-03
Teva Pharmaceutical Industries USD 2.99B 235M 2024-03
Ultragenyx Pharmaceutical USD 112.25M 664.86M 2024-03
Vertex Pharmaceuticals USD 9.16B 1.95B 2024-03



Neurocrine Biosciences 现金及等价物 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.